NCT03038048View on ClinicalTrials.gov

30g vs 33g Needle for Intravitreal Injections

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Age Related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Interventions
PROCEDURE

Varying needle size with intravitreal ranibizumab or aflibercept

Varying gauge of needle, 33 gauge vs 30 gauge

Trial Locations (1)

19107

Mid Atlantic Retina- Wills Eye Hospital, Philadelphia

All Listed Sponsors
collaborator

Mid Atlantic Retina

OTHER

lead

Wills Eye

OTHER

NCT03038048 - 30g vs 33g Needle for Intravitreal Injections | Biotech Hunter | Biotech Hunter